217 related articles for article (PubMed ID: 25081543)
1. The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.
Suico MA; Fukuda R; Miyakita R; Koyama K; Taura M; Shuto T; Kai H
J Biol Chem; 2014 Sep; 289(38):26143-26154. PubMed ID: 25081543
[TBL] [Abstract][Full Text] [Related]
2. MEF/ELF4 transactivation by E2F1 is inhibited by p53.
Taura M; Suico MA; Fukuda R; Koga T; Shuto T; Sato T; Morino-Koga S; Okada S; Kai H
Nucleic Acids Res; 2011 Jan; 39(1):76-88. PubMed ID: 20805247
[TBL] [Abstract][Full Text] [Related]
3. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.
Ando K; Tsushima H; Matsuo E; Horio K; Tominaga-Sato S; Imanishi D; Imaizumi Y; Iwanaga M; Itonaga H; Yoshida S; Hata T; Moriuchi R; Kiyoi H; Nimer S; Mano H; Naoe T; Tomonaga M; Miyazaki Y
J Biol Chem; 2013 Mar; 288(13):9457-67. PubMed ID: 23393136
[TBL] [Abstract][Full Text] [Related]
6. p53 mediates the negative regulation of MDM2 by orphan receptor TR3.
Zhao BX; Chen HZ; Lei NZ; Li GD; Zhao WX; Zhan YY; Liu B; Lin SC; Wu Q
EMBO J; 2006 Dec; 25(24):5703-15. PubMed ID: 17139261
[TBL] [Abstract][Full Text] [Related]
7. The ETS Factor Myeloid Elf-1-Like Factor (MEF)/Elf4 Is Transcriptionally and Functionally Activated by Hypoxia.
Suico MA; Taura M; Kudo E; Gotoh K; Shuto T; Okada S; Kai H
Biol Pharm Bull; 2016; 39(4):641-7. PubMed ID: 27040637
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the mdm2 oncogene by thyroid hormone receptor.
Qi JS; Yuan Y; Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1999 Jan; 19(1):864-72. PubMed ID: 9858609
[TBL] [Abstract][Full Text] [Related]
9. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation.
Stommel JM; Wahl GM
Cell Cycle; 2005 Mar; 4(3):411-7. PubMed ID: 15684615
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
11. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
[TBL] [Abstract][Full Text] [Related]
12. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.
Zhang X; Wang W; Wang H; Wang MH; Xu W; Zhang R
Oncogene; 2013 May; 32(22):2782-91. PubMed ID: 22777350
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic role of the ETS transcription factors MEF and ERG.
Sashida G; Bazzoli E; Menendez S; Liu Y; Nimer SD
Cell Cycle; 2010 Sep; 9(17):3457-9. PubMed ID: 20814243
[TBL] [Abstract][Full Text] [Related]
14. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.
Ayroldi E; Petrillo MG; Bastianelli A; Marchetti MC; Ronchetti S; Nocentini G; Ricciotti L; Cannarile L; Riccardi C
Cell Death Differ; 2015 Jan; 22(1):118-30. PubMed ID: 25168242
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis.
Das A; Chendil D; Dey S; Mohiuddin M; Mohiuddin M; Milbrandt J; Rangnekar VM; Ahmed MM
J Biol Chem; 2001 Feb; 276(5):3279-86. PubMed ID: 11035041
[TBL] [Abstract][Full Text] [Related]
16. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
17. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2.
Liu X; Tan Y; Zhang C; Zhang Y; Zhang L; Ren P; Deng H; Luo J; Ke Y; Du X
EMBO Rep; 2016 Mar; 17(3):349-66. PubMed ID: 26882543
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor tyrosine kinase substrate enhances low levels of MDM2-mediated p53 ubiquitination.
Wang KS; Chen G; Shen HL; Li TT; Chen F; Wang QW; Wang ZQ; Han ZG; Zhang X
PLoS One; 2011; 6(8):e23571. PubMed ID: 21887275
[TBL] [Abstract][Full Text] [Related]
19. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of crosstalk between the p53 and NFκB pathways: MDM2 binds and inhibits p65RelA.
Heyne K; Winter C; Gerten F; Schmidt C; Roemer K
Cell Cycle; 2013 Aug; 12(15):2479-92. PubMed ID: 23839035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
